Cas 500292-98-8,ethyl 4-amino-3-chloro-5-methyl-benzoate

500292-98-8

Post Buying Request

Basic information

Product Name: ethyl 4-amino-3-chloro-5-methyl-benzoate
Synonyms:
CAS NO:500292-98-8
Molecular Formula: C₁₀H₁₂ClNO₂
Molecular Weight: 213.66078
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: ethyl 4-amino-3-chloro-5-methyl-benzoate(CAS DataBase Reference)
NIST Chemistry Reference: ethyl 4-amino-3-chloro-5-methyl-benzoate(500292-98-8)
EPA Substance Registry System: ethyl 4-amino-3-chloro-5-methyl-benzoate(500292-98-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 500292-98-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

500292-98-8 Suppliers

Recommended suppliers

500292-98-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 500292-98-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,0,2,9 and 2 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 500292-98:
(8*5)+(7*0)+(6*0)+(5*2)+(4*9)+(3*2)+(2*9)+(1*8)=118
118 % 10 = 8
So 500292-98-8 is a valid CAS Registry Number.

500292-98-8Upstream product

40800-65-5 1-amino-2-methylbenzene-4-carboxylic acid ethyl ester

500292-98-8Downstream Products

500292-98-8Relevant academic research and scientific papers

Pharmaceutical compositions comprising a basic drug compound, a surfactant, and a physiologically tolerable water soluble acid

-

Page/Page column 54, (2015/12/04)

The invention provides a novel pharmaceutical composition comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base characterized in that the acid respectively base:drug compound ratio is at least 1:1 by weight.

Substituted benzamides with activity towards EP4 receptors

-

Paragraph 0100-0101, (2014/08/20)

The present invention belongs to the field of EP4 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP4 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP4 receptor as well as to pharmaceutical compositions comprising them.

SUBSTITUTED BENZAMIDES WITH ACTIVITY TOWARDS EP4 RECEPTORS

-

Page/Page column 37, (2014/08/20)

Synthesis of novel diarylpyrimidine analogues of TMC278 and their antiviral activity against HIV-1 wild-type and mutant strains

Mordant, Celine,Schmitt, Benoit,Pasquier, Elisabeth,Demestre, Christophe,Queguiner, Laurence,Masungi, Chantal,Peeters, Anik,Smeulders, Liesbeth,Bettens, Eva,Hertogs, Kurt,Heeres, Jan,Lewi, Paul,Guillemont, Jerome

, p. 567 - 579 (2008/02/10)

Novel diarylpyrimidines (DAPY), which represent next generation of non-nucleoside reverse transcriptase inhibitors (NNRTIs), were synthesized and their activities against human immunodeficiency virus type I (HIV-1) assessed. Modulations at positions 2 and

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 500292-98-8